Developing IL-2 Variant Immunocytokines for Immunotherapy of Cancer
Time: 9:25 am
day: Day One
Details:
- Design and preclinical properties of IL-2 variant immunocytokines
- Tumor versus PD-1 targeting
- Application for combination therapy
